TrialJournal of cancer research and clinical oncology2018

Impact of baseline characteristics on outcomes of advanced HCC patients treated with sorafenib: a secondary analysis of a phase III study.

Omar Abdel-RahmanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.